Respiratory ß-2-Microglobulin exerts pH dependent antimicrobial activity.
Armin Holch1, Richard Bauer1, Lia-Raluca Olari2
1Institute of Medical Microbiology and Hygiene, University Hospital , Ulm, Germany.
Researchers discovered beta-2-microglobulin (B2M) in human respiratory fluid acts as an antimicrobial peptide (AMP). This protein disrupts bacterial membranes, showing increased potency at lower pH levels typical of infections.
Area of Science:
- Immunology and Microbiology
- Biochemistry and Molecular Biology
Background:
- The respiratory tract is a primary entry point for pathogens.
- Antimicrobial peptides (AMPs) are key immune defense mechanisms against bacterial infections.
- Novel AMPs are sought for therapeutic applications.
Purpose of the Study:
- To identify novel antimicrobial peptides from human broncho-alveolar-lavage (BAL) fluid.
- To characterize the antimicrobial activity and mechanism of action of identified peptides.
Main Methods:
- Screening of a peptide library from BAL fluid using radial diffusion assays.
- Purification and identification of active antimicrobial compounds.
- Confirmation of activity using commercially available beta-2-microglobulin (B2M).
- Analysis of B2M fragments, pH dependency, membrane integrity (Sytox green uptake), and bacterial morphology (TEM).
Main Results:
- Beta-2-microglobulin (B2M) was identified as an active antimicrobial agent.
- B2M demonstrated dose-dependent inhibition of Pseudomonas aeruginosa and Listeria monocytogenes.
- Antimicrobial activity was localized to the C-terminal region of B2M.
- Activity was enhanced at acidic pH (≤5.5), correlating with bacterial membrane disruption and cell lysis.
Conclusions:
- Beta-2-microglobulin (B2M) exhibits potent antimicrobial activity against Gram-negative and Gram-positive bacteria.
- B2M functions by compromising bacterial membrane integrity, particularly under acidic conditions.
- B2M represents a potential therapeutic candidate for respiratory tract infections.
More Related Videos
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing
